Free Newsletter
Sanofi: No 'major' U.S. deal presented to board
Free newsletter via e-mail
Tools
Hearing rumors that Sanofi-Aventis was looking at a "major" U.S. acquisition? Well, Sanofi denied it presented said acquisition plan to its board, after Les Echos newspaper reported that the drugmaker's major shareholders had deemed the deal too risky. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: